![Roy Hartvig Larsen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Roy Hartvig Larsen
Algemeen Directeur bij Sciencons AS
Vermogen: 193 553 $ op 31-05-2024
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Tina Bjørnlund Bønsdorff | M | 53 |
Oncoinvent AS
![]() Oncoinvent AS Pharmaceuticals: MajorHealth Technology Oncoinvent AS develops antibody based therapeutic molecules for cancer treatment. It offers antigen-binding domains that develops coupling to nanoparticles and drug candidates. The firm provides antibodies (the OI-antibodies) with clinical relevant binding-specificity and also designs molecules and drug conjugates for treatment of specific cancer diseases. The company was founded by Tina Bjornlund Bonsdorff, ?yvind Sverre Bruland, Roy Hartvig Larsen, and Thora Johanna Jonasdottir in 2010 and is headquartered in Oslo, Norway. | 14 jaar |
Thora Johanna Jonasdottir | M | 59 |
Oncoinvent AS
![]() Oncoinvent AS Pharmaceuticals: MajorHealth Technology Oncoinvent AS develops antibody based therapeutic molecules for cancer treatment. It offers antigen-binding domains that develops coupling to nanoparticles and drug candidates. The firm provides antibodies (the OI-antibodies) with clinical relevant binding-specificity and also designs molecules and drug conjugates for treatment of specific cancer diseases. The company was founded by Tina Bjornlund Bonsdorff, ?yvind Sverre Bruland, Roy Hartvig Larsen, and Thora Johanna Jonasdottir in 2010 and is headquartered in Oslo, Norway. | 14 jaar |
Adrian Senderowicz | M | 60 |
Oncoinvent AS
![]() Oncoinvent AS Pharmaceuticals: MajorHealth Technology Oncoinvent AS develops antibody based therapeutic molecules for cancer treatment. It offers antigen-binding domains that develops coupling to nanoparticles and drug candidates. The firm provides antibodies (the OI-antibodies) with clinical relevant binding-specificity and also designs molecules and drug conjugates for treatment of specific cancer diseases. The company was founded by Tina Bjornlund Bonsdorff, ?yvind Sverre Bruland, Roy Hartvig Larsen, and Thora Johanna Jonasdottir in 2010 and is headquartered in Oslo, Norway. | 2 jaar |
Anders Månsson | M | 57 |
Oncoinvent AS
![]() Oncoinvent AS Pharmaceuticals: MajorHealth Technology Oncoinvent AS develops antibody based therapeutic molecules for cancer treatment. It offers antigen-binding domains that develops coupling to nanoparticles and drug candidates. The firm provides antibodies (the OI-antibodies) with clinical relevant binding-specificity and also designs molecules and drug conjugates for treatment of specific cancer diseases. The company was founded by Tina Bjornlund Bonsdorff, ?yvind Sverre Bruland, Roy Hartvig Larsen, and Thora Johanna Jonasdottir in 2010 and is headquartered in Oslo, Norway. | 1 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Per Anders Göte Samuelsson | M | 63 | 8 jaar | |
Tone Kvåle | F | 55 | 8 jaar | |
Øyvind Sverre Bruland | M | 72 |
Oncoinvent AS
![]() Oncoinvent AS Pharmaceuticals: MajorHealth Technology Oncoinvent AS develops antibody based therapeutic molecules for cancer treatment. It offers antigen-binding domains that develops coupling to nanoparticles and drug candidates. The firm provides antibodies (the OI-antibodies) with clinical relevant binding-specificity and also designs molecules and drug conjugates for treatment of specific cancer diseases. The company was founded by Tina Bjornlund Bonsdorff, ?yvind Sverre Bruland, Roy Hartvig Larsen, and Thora Johanna Jonasdottir in 2010 and is headquartered in Oslo, Norway. | - |
Ludvik Sandnes | M | - | 6 jaar | |
Anniken Hagen | F | 61 | - | |
Bjørg Bolstad | F | - | 3 jaar | |
Thomas Ramdahl | M | 68 | - | |
Jónas Einarsson | M | 67 |
Oncoinvent AS
![]() Oncoinvent AS Pharmaceuticals: MajorHealth Technology Oncoinvent AS develops antibody based therapeutic molecules for cancer treatment. It offers antigen-binding domains that develops coupling to nanoparticles and drug candidates. The firm provides antibodies (the OI-antibodies) with clinical relevant binding-specificity and also designs molecules and drug conjugates for treatment of specific cancer diseases. The company was founded by Tina Bjornlund Bonsdorff, ?yvind Sverre Bruland, Roy Hartvig Larsen, and Thora Johanna Jonasdottir in 2010 and is headquartered in Oslo, Norway. | - |
Theresa Comiskey Olsen | F | 61 | - | |
Marco Renoldi | M | 67 | 8 jaar | |
Bente-Lill Romøren | F | 75 | - | |
Jostein Dahle | M | 51 | - | |
Jean Bizzari | M | 69 | - | |
John Berriman | M | 76 | 4 jaar | |
Gisela Schwab | M | 67 | 5 jaar | |
Hilde Hermansen Steineger | M | 58 | 7 jaar | |
Jan Alan Alfheim | M | - |
Oncoinvent AS
![]() Oncoinvent AS Pharmaceuticals: MajorHealth Technology Oncoinvent AS develops antibody based therapeutic molecules for cancer treatment. It offers antigen-binding domains that develops coupling to nanoparticles and drug candidates. The firm provides antibodies (the OI-antibodies) with clinical relevant binding-specificity and also designs molecules and drug conjugates for treatment of specific cancer diseases. The company was founded by Tina Bjornlund Bonsdorff, ?yvind Sverre Bruland, Roy Hartvig Larsen, and Thora Johanna Jonasdottir in 2010 and is headquartered in Oslo, Norway. | 12 jaar |
Stein Holst Annexstad | M | 80 | - | |
Alexandra Morris | F | 62 | 2 jaar | |
Olav Steinnes | M | 67 | - | |
Kari Grønås Dyvik | F | 60 | - | |
Renee Tannenbaum | M | 72 | - | |
Ragnhild Marie Løberg | F | 71 | - | |
Geir Christian Melen | M | 60 | 11 jaar | |
Luigi Costa | M | 59 | 4 jaar | |
Vidar Hansson | M | - | - | |
Björn Ingemar Odlander | M | 66 | 1 jaar | |
Cristina Oliva | M | - | 2 jaar | |
Rita Dege | F | 57 | 5 jaar |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Noorwegen | 33 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Roy Hartvig Larsen
- Persoonlijk netwerk